비교리스트

 카트 문의
시장보고서
상품코드
1545604

세계의 생명과학 소프트웨어 시장

Life Science Software
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 182 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생명과학 소프트웨어 세계 시장, 2030년까지 150억 달러 규모에 달할 것으로 전망

2023년 101억 달러로 추정되는 생명과학 소프트웨어 세계 시장은 2023년부터 2030년까지 연평균 5.9% 성장하여 2030년에는 150억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 클라우드 도입 부문은 CAGR 6.4%를 기록하며 분석 기간 동안 96억 달러에 달할 것으로 예상됩니다. 온프레미스 배포 부문은 분석 기간 동안 4.9%의 CAGR을 기록할 것으로 추정됩니다.

미국 시장 약 28억 달러, 중국은 연평균 5.6%의 성장률로 성장 전망

미국 생명과학 소프트웨어 시장 규모는 2023년 28억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 24억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 5.6%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 5.7%와 4.5%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 4.7%의 CAGR로 성장할 것으로 예상됩니다.

세계 생명과학 소프트웨어 시장 - 주요 동향 및 촉진요인 요약

생명과학 소프트웨어가 연구개발에 필수적인 이유는 무엇일까?

생명과학 소프트웨어는 현대 과학 연구에서 생성되는 방대한 양의 데이터를 관리, 분석 및 해석하는 데 필요한 도구와 플랫폼을 제공하기 때문에 연구 개발(R&D)에 필수적인 요소로 자리 잡고 있습니다. 데이터 관리 시스템, 생물정보학 도구, 실험실 정보 관리 시스템(LIMS) 등을 포함한 이러한 소프트웨어 솔루션은 연구자들이 복잡한 데이터 세트를 정리하고 분석하며, 워크플로우를 간소화하고, 규제 요건을 준수할 수 있도록 지원합니다. 생명과학 산업에서 데이터 기반 의사결정에 대한 의존도가 높아짐에 따라 대규모 데이터 분석 및 통합을 지원하는 고급 소프트웨어 솔루션에 대한 수요가 증가하고 있으며, 생명과학 소프트웨어는 연구 개발 활동에 필수적인 요소로 자리 잡고 있습니다.

기술의 발전은 생명과학 소프트웨어를 어떻게 향상시키고 있는가?

기술의 발전은 생명과학 소프트웨어의 기능을 크게 향상시켜 더욱 강력하고 사용자 친화적인 솔루션을 개발할 수 있도록 돕고 있습니다. 인공지능(AI)과 머신러닝 알고리즘을 소프트웨어 플랫폼에 통합함으로써 보다 정교한 데이터 분석이 가능해졌고, 연구자들은 이전에는 발견하기 어려웠던 패턴과 인사이트를 발견할 수 있게 되었습니다. 클라우드 컴퓨팅도 중요한 역할을 하고 있으며, 대규모 데이터 세트를 저장하고 처리할 수 있는 확장 가능하고 안전한 환경을 제공하고, 지리적으로 분산된 팀 간의 실시간 협업을 가능하게 합니다. 또한, 데이터 시각화 도구의 발전은 연구자들이 복잡한 데이터를 해석하고 연구 결과를 쉽게 전달할 수 있도록 돕고 있습니다. 이러한 기술 혁신은 생명과학 산업 전반에 걸쳐 첨단 소프트웨어 솔루션의 채택을 촉진하고 있습니다.

생명과학 소프트웨어의 채택을 촉진하는 트렌드는 무엇일까?

생명과학 소프트웨어의 채택을 촉진하는 몇 가지 주요 트렌드는 개인 맞춤형 의료에 대한 관심 증가, 빅데이터 및 데이터 분석의 부상, 규제 준수 및 데이터 무결성에 대한 중요성 등 여러 가지를 꼽을 수 있습니다. 개인별 유전자 및 분자 프로파일 분석이 필요한 맞춤의료는 대규모 유전체 및 임상 데이터를 관리하고 분석할 수 있는 소프트웨어에 대한 수요를 촉진하고 있습니다. 또한, 빅데이터와 데이터 분석 트렌드는 최신 연구에서 생성되는 방대한 양의 데이터를 처리하고 해석할 수 있는 고급 소프트웨어 솔루션의 필요성을 증가시키고 있습니다. 또한, 규제 준수와 데이터 무결성에 대한 관심이 높아지면서 정확한 기록 관리와 추적성을 보장할 수 있는 소프트웨어 솔루션의 도입이 촉진되고 있습니다. 이러한 추세는 생명과학 소프트웨어 시장의 역동적인 성장에 기여하고 있습니다.

생명과학 소프트웨어 시장의 성장을 촉진하는 요인은 무엇일까?

생명과학 소프트웨어 시장의 성장은 연구 개발에서 데이터 기반 의사결정에 대한 수요 증가, 개인 맞춤형 의료의 부상, 규제 요건 준수 필요성 등 여러 가지 요인에 의해 주도되고 있습니다. 유전체학, 단백질체학 및 기타 데이터 집약적인 분야의 확대로 인해 대규모 데이터 세트를 관리하고 분석할 수 있는 소프트웨어 솔루션에 대한 수요가 증가하고 있습니다. 또한, 생명과학 산업이 디지털 전환으로 전환하면서 워크플로우를 간소화하고 효율성을 향상시키는 소프트웨어 솔루션의 채택이 증가하고 있습니다. 또한, R&D 활동이 엄격한 기준에 부합하는지 확인하기 위해 데이터 무결성 및 규제 준수에 대한 중요성이 강조되면서 시장 성장에 박차를 가하고 있습니다. 생명과학 산업이 지속적으로 발전함에 따라 첨단 소프트웨어 솔루션에 대한 수요는 시장의 지속적인 성장을 촉진할 것으로 예상됩니다.

조사 대상 기업 예시(주목받는 14개 기업)

  • ArisGlobal LLC
  • Ducen IT
  • DXC Technology
  • EPAM Systems, Inc.
  • Fujitsu Ltd.
  • GE Healthcare
  • HCL Technologies Ltd.
  • Instem Group of Companies
  • Medidata Solutions, Inc.
  • Oracle Corporation
  • PDS
  • SAP SE
  • SAS Institute, Inc.
  • Signiant, Inc.
  • Veeva Systems, Inc.
  • Xybion Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 24.09.10

Global Life Science Software Market to Reach US$15.0 Billion by 2030

The global market for Life Science Software estimated at US$10.1 Billion in the year 2023, is expected to reach US$15.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$9.6 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.6% CAGR

The Life Science Software market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 5.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Life Science Software Market - Key Trends & Drivers Summarized

Why Is Life Science Software Becoming Essential in Research and Development?

Life science software is becoming essential in research and development (R&D) as it provides the tools and platforms necessary for managing, analyzing, and interpreting the vast amounts of data generated by modern scientific research. These software solutions, which include data management systems, bioinformatics tools, and laboratory information management systems (LIMS), enable researchers to organize and analyze complex datasets, streamline workflows, and ensure compliance with regulatory requirements. As the life sciences industry increasingly relies on data-driven decision-making, the demand for sophisticated software solutions that can handle large-scale data analysis and integration is growing, making life science software a critical component of R&D activities.

How Are Technological Advancements Enhancing Life Science Software?

Technological advancements are significantly enhancing the capabilities of life science software, leading to the development of more powerful and user-friendly solutions. The integration of artificial intelligence (AI) and machine learning algorithms into software platforms is enabling more advanced data analysis, allowing researchers to uncover patterns and insights that were previously difficult to detect. Cloud computing is also playing a key role, providing scalable and secure environments for storing and processing large datasets, and enabling real-time collaboration across geographically dispersed teams. Additionally, advancements in data visualization tools are making it easier for researchers to interpret complex data and communicate their findings. These technological innovations are driving the adoption of advanced software solutions across the life sciences industry.

What Trends Are Driving the Adoption of Life Science Software?

Several key trends are driving the adoption of life science software, including the increasing focus on personalized medicine, the rise of big data and data analytics, and the growing emphasis on regulatory compliance and data integrity. Personalized medicine, which requires the analysis of individual genetic and molecular profiles, is driving the demand for software that can manage and analyze large-scale genomic and clinical data. The trend towards big data and data analytics is also increasing the need for sophisticated software solutions that can process and interpret vast amounts of data generated by modern research. Additionally, the growing emphasis on regulatory compliance and data integrity is encouraging the adoption of software solutions that can ensure accurate record-keeping and traceability. These trends are contributing to the dynamic growth of the life science software market.

What Factors Are Driving the Growth of the Life Science Software Market?

The growth in the life science software market is driven by several factors, including the increasing demand for data-driven decision-making in research and development, the rise of personalized medicine, and the need for compliance with regulatory requirements. The expansion of genomics, proteomics, and other data-intensive fields is creating a demand for software solutions that can manage and analyze large datasets. Additionally, the shift towards digital transformation in the life sciences industry is driving the adoption of software solutions that can streamline workflows and improve efficiency. The growing emphasis on data integrity and regulatory compliance is also fueling market growth, as organizations seek to ensure that their research and development activities meet strict standards. As the life sciences industry continues to evolve, the demand for advanced software solutions is expected to drive sustained growth in the market.

Select Competitors (Total 14 Featured) -

  • ArisGlobal LLC
  • Ducen IT
  • DXC Technology
  • EPAM Systems, Inc.
  • Fujitsu Ltd.
  • GE Healthcare
  • HCL Technologies Ltd.
  • Instem Group of Companies
  • Medidata Solutions, Inc.
  • Oracle Corporation
  • PDS
  • SAP SE
  • SAS Institute, Inc.
  • Signiant, Inc.
  • Veeva Systems, Inc.
  • Xybion Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Life Science Software - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Cloud Computing Propel Adoption of SaaS Solutions in Life Sciences
    • Shift Towards Integrated and Scalable Software Expands Addressable Market
    • Rising Focus on Clinical Trial Management Drives Adoption of Advanced Software Solutions
    • Growing Demand for Digital Transformation Spurs Growth in Life Science Software
    • Technological Innovations in AI and Machine Learning Enhance Capabilities of Life Science Software
    • Expanding Use of Software in Drug Development and Pharmacovigilance Generates New Opportunities
    • Rising Importance of Software in Health Economics and Outcomes Research (HEOR) Strengthens Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Life Science Software Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Life Science Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Life Science Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Life Science Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Active Players in United States
    • TABLE 20: USA Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • CANADA
    • Active Players in Canada
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • JAPAN
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Active Players in Japan
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • CHINA
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Active Players in China
    • TABLE 38: China Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • EUROPE
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Life Science Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Life Science Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Life Science Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • FRANCE
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • Active Players in France
    • TABLE 53: France Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • GERMANY
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • Active Players in Germany
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • ITALY
    • Active Players in Italy
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • Active Players in United Kingdom
    • TABLE 71: UK Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • Active Players in Rest of Europe
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Active Players in Asia-Pacific
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • Active Players in Rest of World
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제